AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a disorder characterised by ...
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...
U.K. stocks were subdued on Friday, a day after the Bank of England cut interest rates as expected but signaled stickier inflation.
6,7 Nasal polyps can block nasal passages and lead to breathing problems, difficulty in sense of smell, nasal discharge, ...
TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...
That includes a £25m profit hit in the current financial year, which will also be impacted by reduced expectations for sale ...
European stocks drifted lower on Friday as China's top legislative body - the National People's Congress (NPC) - approved the State ...
BA and Iberia owner IAG flew to the top of the index as it posted a 15% jump in third-quarter operating profit to €2.01bn and ...
In Fortune's "Change the World 2024" rankings, Viettel Group ranks 3rd among over 50 global companies contributing significantly to sustainable development and positive social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback